Skip to main content
Data show positive results for Medtronic's drug-coated balloon

Two-year real-world data from a study involving a patient cohort with a mean lesion length of 12.09 cm showed the use of Medtronic's In.Pact Admiral drug-coated balloon demonstrated an 83.3% rate of freedom from clinically driven target lesion revascularization. Four-year results from a separate study also showed that use of the device led to a longer period of time to reintervention and a higher freedom from CD-TLR rate, compared with percutaneous transluminal angioplasty.

Full Story: